Disease-Specific Quality-of-Life Measures Mapped to the EQ-5D in a Chronic Disorder With Recurrent Attacks: Analysis of the Deliver Trial in Patients With Migraine
Author(s)
Jönsson L1, Regnier SA1, Kymes S2, Awad SF3, Talon B3, Lee XY3, Goadsby PJ4
1Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden, 2H. Lundbeck A/S, Copenhagen, IL, Denmark, 3H. Lundbeck A/S, Copenhagen, Denmark, 4NIHR-Wellcome Trust King’s Clinical Research Facility, King’s College, London, UK
Presentation Documents
OBJECTIVES: Recall period is important when selecting appropriate patient-reported outcomes (PROs) for generating health utilities. People living with migraine experience variation in their daily experience, which may not be well captured using generic quality-of-life measures such as the EQ-5D with its 1-day recall period. In this post hoc analysis of the DELIVER (NCT04418765) migraine-prevention trial, we compared utilities estimated from 3 PRO measures—EQ-5D-5L, Migraine-Specific Quality of Life Questionnaire (MSQ; 4-week recall), and 6-item Headache Impact Test (HIT-6; 4-week recall) to assess the extent to which these measures capture migraine impact. The relationship between utilities and monthly migraine day (MMD) reduction was also examined with the 3 PRO measures.
METHODS: MSQ and HIT-6 were mapped to EQ-5D-3L using previously published algorithms. Utilities were estimated for each study visit (up to 24 weeks) at which the HIT-6, MSQ, and/or EQ-5D-5L was completed. A mixed linear model comparing number of MMDs and utility score was estimated for each instrument. The base-case model estimated the relationship between utilities and MMDs independent of treatment group.
RESULTS: Analysis of MSQ and HIT-6 showed a similar relationship with changes in MMDs (average utility decrement per MMD [95% CI]: MSQ, 0.0189 [0.0180, 0.0198], p<0.001; HIT-6, 0.0188 [0.0181, 0.0195], p<0.001). Relative to MSQ and HIT-6, EQ-5D-5L was less responsive to MMD changes (0.0053 [0.0048, 0.0059], p<0.001). When pooling or stratifying patients (n=337) by migraine type, a linear correlation between migraine presence during the day of EQ-5D-5L completion, migraine severity, and scores obtained using EQ-5D-5L was observed: presence and severity impacted the utility estimate (values ranged from 0.62–0.92).
CONCLUSIONS: Measures with a short recall period may not fully capture migraine’s impact on a patient’s life and functioning. Thus, this work highlights the importance of investigating different approaches that may be used to generate health utility data.
Conference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
PCR4
Topic
Methodological & Statistical Research, Patient-Centered Research
Topic Subcategory
Health State Utilities, PRO & Related Methods
Disease
No Additional Disease & Conditions/Specialized Treatment Areas